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11. Introduction.
Recognition and destruction of forcif^n cells and other matter Is a
normal function of the immune system. Under pathologic circumstances,
the regulation of 1mmunol.c: •1c homeostasis is altered so that normal
autologous cells are destroyed, resulting in autoimmune disease (Boyd,
1970, pp. 15(-176). One fora of autoii.-nune disease is rheumatoid arth-
ritis (Boyd,'1970, P. 173).
Some immune response are effected through immunoglobulins (Ig),
of which five classes have beer, recognized, namely, IgA, IgD, Ig-P , IgG,
and If-;4 (Franklin, 1.976). 'These IC's represent a heteroGenous collec-
tion of antibodies that can be distinguished from one another by certain
physical charactcri:tics such as sedimentation coefficient, electro-
phoretic mobility, and antigenic specificities. Variable regions within
each Ig class are believed responsible for functional and other hetero-
geneity within each class (Richards et al., 1975; Marx, 1975; and Kolata,
197h).
Auto-antibodies associated with rheumatoid arthritis, termed rheu-
matoid factors (RI') react with antigenic determinants on IgG heavy
chains. RF has predominantly but not completely Ig'.•: specificity. A
number of laboratory tests have been developed such as the Igr,-coated,
ldlatex particle agglutination test (I.abat and layer, 1967, p. 90; Bartfi(.
and Epstein, 1969). We have observed that RF is detected in the majority
of patients with certain solid tumors who have received prior chemo-
therapy or radiotherapy M omey et al., 1976). This auto-anitbody
response was not detected in treated patients with primary brain tumors
(where tissue is sequestered from the imr.une system by an intact blood-
brain barrier) or :rich multiple rlveloma where humoral immunity is usually
impaired. In addition, the Prevalence of RF is not increased with solid
tumors prior to initiation of chemotherapy or radiotherapy. It is pro-
posed that R; is related to prior chemotherapy or radiotherapy of tumor'
anatomicall y ucccs-:;iblc to iirmunolor is tis..ucs c_ipable of antibody
responses. A prir:.ary TgG response o^.cur:, antigen-antibody complexes
form, complexed IrG becomes i,rmunologi.c, an^ an RF response results.
V
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It was further observed in this laboratory that RF causrd comp] - - - - • -
dependent inJury to cells released from bladCer tumors. This cytotox- 	 I
icity was target specific in that cells from a variety of normal tissues
were not diviaged by RF. The specificity of the cell that is the target
for RF-related cytotoxicity and amboceptor requirements for the phenom-
enon become issues of immediate importance in the field of tumcr-host
interactions.
'Three areas for future efforts were identified; 1) to study the
specificity of RF-related target cells, 2) to identify requirements for
RF-related tumor cytotoxicity and to distinguish this host response from
other toxic substan^es in blood of cancer patients, and 3) to determine
factors and kinetics related to this RF response in vivo, including the
antigen specificity of this 11F relative to RF from patients with rheu-
matoid arthritis. The isolation and purification of RF from plasma is
critical to this projected wor%. These procedures con-plement objectives
of the Bioprocessing Office at the Johnson Space Center of the national
Aeronautics and Space A:uninistration. Therefore a Nk-',A-funded contract
to support these efforts was approved on Octobcr 1, 1975.
2. Isolation of FIeumatoid Factcr from Plc^ma.
It was first necessary to extract RF-from plasma to permit its
individual study and, conversely, to test for cytotoxicity in plasma
depleted of RF. Plasma frcm volunteer patients with rheumatoid arth-
ritis was selected for pilot studies. Jieparinized blood was used in
these studies.
a. RF Sen<,ration Procedure.
Plus inu with high RF titers (latex-binding test l ) was adsorbed
using aL;gregated human (-,=-:aglobulin and then eluted with glycine-phoe:-
ph to buffer (pa 2.3) (lleCarvalho et al., 156h; Torrigiani et al., 1970);
eluted RF was resuspended in r'LV::tPhate--buffered saline (pii 7.2) (Reimer
and Schwartz, 1961). Vulwac was reduced by vacuum iialysis to the
original numb,, , %.f r.:.l. plasma. The concentrzationo of :iF in the original
r1 ,:,,,:i, the dial.ysate, and in the adsorbed nlc.:::::L were deter:iined. The
tiyiund, t.'ivision Travenol Laboratories, Inc. , Costa 1•'.esa,
Cnl i f ort? i a , 926,16 .
3original plasma had an RF titer of 1:1260, the dinlysate a titer of
1:640, whereas the: adsorbed pla3m-t was negative in n dilution of 1:20.
b. Furity of Oet crated RF.
Once separated in this manner, the purity of the dinlysate for
RF was considered. Of foremost concern wa: the presence of Ig, without
RF activity or Ig of a class other than I(;'.•1 (IgG contamination could
lead to confusion through amboceptor activity). Irmunodiffusion in
0.8 % agurese medium was therefore performed on the dinlysate (Ouch-
terlony, 1958).
In addition to Ig.1, the dinlysate contained some molecules with IgG
specificity. The most likely -ource of this IgG was the adsorbwit with
test pla., ma but an alternative possibility. This IgG also could posseas
RF activity (Franklin et al., 1957; Eeelman et al., 1958). Effort:: are
currently underway to remove this IgG. On immune ad::orbant columns,
so:ae but not all IgG contaminant was removed. Failure of complete
removal may be due to denaturation. Further efforts to overcome this
obstacle are underway; preliminary experience is prornisinr. In support
of this purification effort, th-rourh co,labortLtion with the :pace Rio-
processing Office of the Johnson Space CeriLer, a small. amount of dial-
ysate was submitted to the Space Sciences Division of General. Electric
for further separation on a very sophisticated continuous flow electro-
phoresis system designed for use in space flight conditions. In the
preliminary experiments, four frnetionc were identified, three of which
have varying amounts of RF activity, the total of which contains 100
of the IT activity and only 57 o of the protein content present in the
original :<,_,mple (Griffin, 1976). The IrG content of these four frac-
tions is wider test.
3. ?2F ;fediated C. totoxic ity ^tu3ies
Once sufficiQnt preparations of HY was obtained (even though not
complet.c, ly pure), its effects en tenor cell suss^n^ivn- were studied.
Tumor tissue was obtained from surgical rpecimcns. This was done with
approval of t`-.e attcndini; ;)riyzic' • .:i:: and of tier: appropriate institutional
4human studies committees.	 .pecimens proved variable in the viability of
freshly freed cells. This is a technical area presently the subject of
technological study.
Tumor specimens were irynediately placed in cold, sterile, minianal
essential medium? . Cells were gently teased with an eighteen gauge
needle while concomitantly perfusing the tissue with minfin%l essential
medium. The cells were then washed three times at 14 0 C. and resuspended
in minimal essential medium. The number of live cells was determined
using the Trypan Blue exclusion (Han'r.s and Wallace, 1958) after which
the cell density was -standardized at 5 X 106 live cells per ml.
The complement-mediated cytotoxic influence of rheumatoid factor
on this cell suopension was then evaluated (Klein, 1971; Stewart and
Goldstein, 197 1+). Cell death was determined in incubations that in-
cluded 0.05 ml. of fresh non.ial pla::ma (complement), 0.05 mi. of dialy-
sate, 0.05 ml. of saline, and 5 X 10 5 cells in 0.1 ml. of medium paired.
Incubations included heat-inactivated complement. Then 0.25 ml. of
pronase (5 mg. per 100 ml. saline) was added and incubation continued
for a further thirty minutes at 370 C. Pronase solubilizes injured
cells (Stewart and Goldstein, 1.97 1'). Thud a decline in hemocytometer
cell count relative to the count in the paired decomplemented incubation
(100	 viability) waz reflective of cell dar.rige.
The cytotoxic Affect of R'r varied from one tumor to another. The
observed percenta.ges of cells dammed by RF are listed in Table I.
Althouc;h these percentages are variable (21. 1 to 91.0"), significant
cytotoxicity is evident. The range of this data is in ar*reement with
that observed in other investigations of imr.'une-related tumor cell-
specific cytotoxicity (0,7oolc et al. , 197 1:; Hellstr"tn and Iiel.lstro:n,
197 1 ' ) .
1 '. Sen arat on o f "' : r--Associa'.ed Ccl.l Po uul.ations .
A problem related to the question of whether PF wt:s toxic to tiLmor
cell: or to ocher cells present in tu:aor tis: ; ue. Other cells include
';! . and Island	 cal 	 .;ew York, 1407?.
J
Table I
Percent Coll Death Mooci ated with M unatoid
Factor in Cell Suspensiuns from Vurious Tumors.
I
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4	 w
Tumor Tissue Scurc.,
Bladder tumor
Bladder tumor
Bladder tumor
Bladder tumor
Myeloma cells from an eff4oion
Malignant pleural effusion (type unknown)
A rcent Cell Death
87.0
69.5
37.3
21. 1;
38.2
91.0
J
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lymphocytes, mZCrop?:zee:., rrun'.11C1 Cytc. , and -tromal cells. l.n r.dditional
problem was the removal of cells that were in,)ur^d before being added to
the test incubation. Such d!ennrA cells could Interfere with test
reactions by adsorption of essential reajentc such a: RF and thereby
sequesteriug them from the reaction under test Consequently it was
felt desirable to develop a method of separating these cell typeL so
that the specificity of RF cytotoxicity could be identified with partic-
ular tttri;et cells
The method of cell separation considered initially was centrifura-
tion within a density gradient of Ficoll-Hypaque (138yum, 1969; Terasaki,
1972, p. 50). Ccntrifut;ation at a speed of 1250 rpm. ( 1+00 G.) for
twenty minutes in P. solution of 10 m1. of 9.0 7 Ficoll and 2.75 ml. of
50
	
sodium hypaque removed erythrocytes b.! sedimentation, but had little
additional merit.
Therefore a density gradient method using human albtsnin was eval-
uated (Dickey, 1.975). Ti ►e colloidal nature of albumin in solution is a
retardant to the mixing of different layers in the gradient column, thy:::
enabling a multiphase density separation column. A1bivain, similar to
Ficoll-Hynaque, is non--toxic to cells.
Initially rcveral combinations of albuniin solution; 4cre used in
constructing; the column to determine the combination most suitable for
cell separation. The range of concentrations o f these solutions was from
7 % to 27 r albu:iin. Cell suspensions from twelve tumor specimens were
separated in thi:. manner. Cell viability, determined by dy„ exclu-sion
(flanks and WU11%ce, 1.95F), was me,.eured in the fractions and compared to
the viability of the su^uen.ion prior to separation. The difference
between the perccntaRc of live cells found in a particular albumin frac-
tion and that found in the original suspension war, calculated as a men-
sare of i`.o viable cell enrichment rtchicved in that fraction. There was
l.it.tic difference apparent in the fraction: of albu:ain concentration less
thwi 17 15 or greater tiian 25 %. Therefore 	 were grouped
together with those of t':e 17	 and 25 r albir riin irar*bons respeetivf.ly
in the data scan ►ri zc:d in Tfiblc II . Some- success Is evident from the
.'owever corj:; i de: rable variabi 1 1 t;	 . t?i different to ::ors is ap; :.rent..
L,
r
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Table II
Increase in Percent of Viable Tumor Cells by
Separat' on on an Albumin I)en ;. i ty Grudi ent .
}Fraction (Albumin Concentration)
<	 <.Tumor Cell .source 1	 1 r21	 ,^ f+23	 f ?_ ^ Bottom
Bone marrow -38.4 -14.9 0.7 0.2 -8.3
None narrow -62.3 1+.1 8.5 3.3 0.6
Breast 2.0 -1.9 -1.9 3.2 -6.2
Bladder 34.1 15.1 18.1 1+.1 -9.9
Larynx 57.6 1+1.6 2-.6 50.6 -30.5
Neck. mass 27.6 23.6 7.6 16.4 -2.11
Breast 3.2 2.8 0.6 -1.7 -2.2
Breast 22.6 2.2 3.8 - 9.1+ - 4.0
133.addcr 35.3 5.5 -1+.0 -12.0 -15.4
Bone wirrow -8.7 31.0 1)5.0 12.0 -1.5
Bone marrow -11.3 -7 1.1 2.1 -1.8
Pleural. effusion 0 . l+ -0.8 l+ .1 2.7 -6.6
^ V
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Tn cells frcm malignant effuuions (Table ITT), enrierhnent in v: ]v
cells was increased in the 2.1 %, 23 1, arid 25 " albumin tractions, with
the greatest enrichment in the 23 % fraction. A decreased percentage of
vaable cells in comiiarison to that of the vriginal cell suspension,
which can be interpreted as an enrichment of dead cell:, was observed in
the top (17 i^ albumin) and bottom (solid pel.l.et in bottor► of centrifuge
tube) fractions.
The results of separating cell. suspensioric derived from the seven
solid tumors (Table IV) are also suggestive of a separation of viable
cells from deud cells but the pattern of .cparution is quite different
from that ob s erved with fluid type tumor sources. With solid tumors,
the greatest percentage of live cells was found in the 17 r albumin
fraction and the enri.ctiment of live eclls become less; as the albumin
concentration was increased. An :.ctual enrichment of dead cells was
evident in the bottom (solid Pellet) fraction of the gradient column.
The separation of viable cells surrested by these results was
encouriZing, Pa,rticularl;; with respect to solid tu^ ►ors. An expansion
of the ranj;c of concentration gradients was then considered as a pos-
Bible means of improving the delineation of these cell populations. To
evaluate this: possibility, al.bu;nin concentrations of 14 %, 18 `J', 22 q,
and 2E 5 were used. As before, the tumor cell sources are classified as
either fluid or solid. The results are presented in Tables V and V1
respectively.
'The measurements of enriched viable cell content in suspensions
from fluid turiors was not suggestive of an improvement in separation
using this new combination of albumin :solutions. However these results
are based upon only two spcciragas.
In contrast, use of this expanded ranee of albumin concentrations
seemed to result in a much sharper separation of cells derived from solid
tumors. Not only were the albumin fractions more enriched with viable
cell: but the increased percentage of dead cells in the bottom Pellet
was even E;reater with this gradient combination. ;since it is the live
cells. that are of intereot to the Present studies of cytotoxic effects,
these results are quite rel-va.-A.
^ __—_
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Table III
Increase in Percent of Viable %,nor Cells from Malignant
Effusion s- Separated by Albumin Density Cri-dient Centrifugation.
Fraction (Albumin Concentration)
Tumor :source 1"i	 r 21 0 23 ` ?5 " Bottom
Bone marrow -38.1+ -1.1+.9 0.7 0.2 -8.3
Boric harrow -62.3 4.1 8.5 3.3 0.6
Bone marrow -8.7 31.0 25.0 12.0 -1.5
Boric marrow -11.3 -7.2 1.1 2.1 -1.8
Plc-.,ral effusion 0.4 -0.8 4.1 2.'( -6.6
Mean,	
-1?.1
	
2.4	 6.3	 4.1	 -8.3
J
10
Table IV
Increvse in Percent of Viable Cells-from Solid
Tumors and :separated by Albumin Density Gradient.
. Fraction (Albumin Concentration)
Tumor Source 17 a 21 % 23 Bottom
breast 2.0 -1.9 -7.9 3.2 -6.2
Bladder 311.1 15.1 18.1 4.1 -9.9
Larynx 57.6 )o .6 23.6 50.6 -30.5
Neck mass 27.6 23.6 'r.6 16.4 -2.)1
Brc,ast 3.2 2.8 0.6 -7.7 -2.2
Breast 22.6 2.2 3.8 -9.1+ -)4.0
Bladder 35.3 5.5 -4.0 -12.0C -15. ► +
1	 r
!kcal	 26.1	 12.7	 8.8	 9.3
	
-10.7
11
Table V
Increase in Percent of Viable
Malignant Eff ,6ions by Album
Fraction (Albumin
'Arnor Source	 14 5	 ] 8 5
Bone marrow	 -33.0	 -24.1
Pleural effuzion	 -h8.7
	
8.2
Cells Separated from
in Density Gradient.
Concentration)
22	 26 50	 Bottom
-4.6	 1.1	 -8.3
12.6	 -1.2	 6.8
Mears	 -40.9	 -8.0	 4.0	 -0.1	 -0.8
1 [,	 • i
Table VI
Increase in Percent of Viable ^ells from
Solid Tumors and Separated by Alb=.in Density Gradient.
Fraction (/{!burin Concentration)
TtLmor Source 14 % 18 2?	 co? 26 o Bottom
Prostate -11.7 8.6 -0.9 5.6 -5.8
Bladder 26.5 16.1 -3.2 -23.0 -38.7
Penis 38.5 46.6 1+5.7 32.0 -29.7
Ovary 53.2 63.5 54.3 46.7 -21.7
Bladder 45.8 148.1 42.9 36.3 -34.2
!dean	 30.5	 36.6	 . 27.8	 19.5	 -26.0
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lot only was it considered de: irable to remove the dead cells from
the cell suspension but it was also considered important to identify and
isolate the various populations of cells involved in the cytotoxic mech-
anism. In this particular study, it would be valuable to '46olate the
neoplastic target cells from the effector cell group or groups. In
order to assess the efficiency of the albumin gradient method in sep-
arating these cell types, slides were made of the cell population ob-
tained from each fraction, subsequently stained with Wrirht's Stain,
and analyzed microscopically for differential cell composition. These
differential cell counts were compared to that of the o. •iji.nal cell
suspension to determine if cnrielLnent of any cell type had occurred as
a result of the separation procedure.
lliere was no evident Pattern of separation based upon cell types
in the results of this part of the study. Cytological analysis of
additional specimens and improved staining methods may be of help in
clarifying a possible pattern of separation.
One such staining method being considered is specific for IgG or
lgM oil the cell membrane surface (Taylor and Skinner, 1976; Taylor and
Burns, 19711). '"he specificity of im:aunoCjobulir.s and their receptors
on cell membrane surfacers are considered by many to be a principle
factor in effecting cell-mediated immune reactions such as cytotoxicity
of tumor cells (Marchalonis, 1975; Rowlands and Drcii.cle, 1975; Vitetta
and Uhr, 1.975; '.funt and Williams, 19'( )4; Scoria, 1976; Metzgar et al..,
1975; Kolata, 1975; Kulczycki et al., 1974; Irie and :1ort.on, 1.974).
These iacribrane surface immunoglobul.ii,s, because of their specificity,
may enable an improved system of cell identification by means of immuno-
globulin-specific staining; reactions. This possibility is further
substantiated by the investiFative efforts of Choi et al. (1974) who
have outlined a general method for isolation and recovery of B lyirpho-
cytes bearing sperlific receptors. Aprerliinina.r% ,
 test of the peroxid%t ,O-
conjugated iirr.aLno-specific st.^inir.; method described by Taylor (1976)
was performed on a small. number of slides of the cells separated by
the album l.n ', r•tdtent mf:thod in the pre:;ent study. The seprclii^imiry
re s ultc arc inuicativc of a*r excel.lf_•nt :;taininr_- zpi-ci;icity. Should
rI 
	
— .' — n..,,,on
1).
further tests of this 5taininr meti:od sue,:-'_,Lntiatc- this potential value,
this method may be very useful in identifying Innmune responsive cells of
refined functional specifIcity, which would be very ap plicable to further
clarification of the mechanisms of tumor immunology.
5. Problems.
Tissue availability has to some extent slowed prcq ress. Successful
uegotiati.cns to have a reservoir of human tumors implanted into a large
colony of nude mice should now overcome this difficulty. This also
eliminates the presence of human 1, ,mphocytes and renders amboceptor
ammenabl.e to experimental control. In addition, the use of tumors such
as malignant melanoma will overcome much of the difficulties exper_enced
in this part related to cell identity. We propose this approach as
being likely to provide us with an adequate supply of human material
suitable for our cytotoxicity.
6. Expenditure sirn"-iry.
The expenditures as of 3/31/76 are listed in Table VII. The funds.
remaining seem adequate for the anticipated expenditures in the com-
pletion of this contract.
7. Conclusi ons.
Uurine the initial six months of this contract, advances were made
in several areas rele l ant to the complement-mediated destruction of neo-
plastic cells. Methods of separating mixed cell suspensions into frac-
tions of viable and non-viable cells were examined and one, an albumin
gradient centrifuration method appears to be applicable in this respect.
Adsorbed RF was prepared and submitted for electrophoretic analysis,
which resulted in the identification of several fractions varying in
activit .
A	 ^-oxidase-conjugated im-nuno-specific staining method for identi-
fying r .-,3es of I^, present on cell r.^embr^ne surfaces was tested and
appears promisin g,  a:, a research too]. in fiirther :studies of cytot.oxic
action.
15
`fable VII
Sirmary of Expenditures to 3/31/76
C11te rr,or,3 Dollars Spent Dol ] ars Remri i nin-
Salaries 8,049.9'( 10,208.24
Supplies 1,84), . 89 3,652.11
Travel 352.00 148.00
Fringe Benefits '150.51 985.88
Indirect Costs 1,988.00 2,52.1.00
I
7iE
Lastly, through these efforts, a general understanding of the
requirements for studying this cell-mediated cytotoxicity aa:, achieved
and will be a soun,? basis for approaches to further selected studies
in this area.
ti
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